Literature DB >> 11931676

Predicting depressive symptoms with a new measure of shame: The Experience of Shame Scale.

Bernice Andrews1, Mingyi Qian, John D Valentine.   

Abstract

OBJECTIVE: To investigate whether previous findings from interview studies of a prospective relationship between shame and psychopathology (e.g. Andrews, 1995) could be replicated using questionnaires.
DESIGN: A total of 163 university students participated in a longitudinal questionnaire study.
METHOD: The Experience of Shame Scale (ESS), a questionnaire based on a previous interview measure, and an established shame scale (TOSCA), were considered in their relation to depressive symptoms assessed at two time points 11 weeks apart.
RESULTS: Both scales made significant independent contributions to depressive symptoms at time 1. However, only the ESS predicted additional significant variance in time 2 symptoms when time 1 symptoms were controlled.
CONCLUSIONS: It was concluded that the reason for the differential performance of the two scales was that the ESS, like the shame interview, assesses specific areas of shame related to self and performance, whereas the TOSCA assesses general shame and may therefore be more prone to mood-state effects.

Entities:  

Mesh:

Year:  2002        PMID: 11931676     DOI: 10.1348/014466502163778

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  55 in total

1.  Application of syndemic theory to black men who have sex with men in the Multicenter AIDS Cohort Study.

Authors:  Typhanye Penniman Dyer; Steve Shoptaw; Thomas E Guadamuz; Michael Plankey; Uyen Kao; David Ostrow; Joan S Chmiel; Amy Herrick; Ron Stall
Journal:  J Urban Health       Date:  2012-08       Impact factor: 3.671

2.  Neglected children, shame-proneness, and depressive symptoms.

Authors:  David S Bennett; Margaret Wolan Sullivan; Michael Lewis
Journal:  Child Maltreat       Date:  2010-08-19

3.  The development and psychometric properties of the HIV and Abuse Related Shame Inventory (HARSI).

Authors:  Sharon A S Neufeld; Kathleen J Sikkema; Rachel S Lee; Arlene Kochman; Nathan B Hansen
Journal:  AIDS Behav       Date:  2012-05

4.  The development and initial validation of the Terminally Ill Grief or Depression Scale (TIGDS).

Authors:  Vyjeyanthi S Periyakoil; Helena C Kraemer; Art Noda; Rudolf Moos; James Hallenbeck; Maria Webster; Jerome A Yesavage
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

5.  Changes in Problematic Anger, Shame, and Disgust in Anxious and Depressed Adults Undergoing Treatment for Emotion Dysregulation.

Authors:  Andrada D Neacsiu; Joscelyn Rompogren; Jeremy W Eberle; Kibby McMahon
Journal:  Behav Ther       Date:  2017-10-27

6.  A pilot randomized controlled trial of Dialectical Behavior Therapy with and without the Dialectical Behavior Therapy Prolonged Exposure protocol for suicidal and self-injuring women with borderline personality disorder and PTSD.

Authors:  Melanie S Harned; Kathryn E Korslund; Marsha M Linehan
Journal:  Behav Res Ther       Date:  2014-02-11

7.  Factor structure, factorial invariance, and validity of the Multidimensional Shame-Related Response Inventory-21 (MSRI-21).

Authors:  Antonio F Garcia; Melina Acosta; Saifa Pirani; Daniel Edwards; Augustine Osman
Journal:  J Couns Psychol       Date:  2017-02-09

Review 8.  Narcissistic personality disorder: an integrative review of recent empirical data and current definitions.

Authors:  Stefan Roepke; Aline Vater
Journal:  Curr Psychiatry Rep       Date:  2014-05       Impact factor: 5.285

9.  Treatment preference among suicidal and self-injuring women with borderline personality disorder and PTSD.

Authors:  Melanie S Harned; Mathew A Tkachuck; Kelly A Youngberg
Journal:  J Clin Psychol       Date:  2013-02-26

10.  Adversity and syndemic production among men participating in the multicenter AIDS cohort study: a life-course approach.

Authors:  Amy L Herrick; Sin How Lim; Michael W Plankey; Joan S Chmiel; Thomas E Guadamuz; Thomas T Guadamuz; Uyen Kao; Steven Shoptaw; Adam Carrico; David Ostrow; Ron Stall
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.